Rethinking the Gray Zone: Landmark SINGLE-AF Trial Proves Efficacy of DOACs in Intermediate-Risk Atrial Fibrillation
Executive Overview The landscape of cardiovascular medicine stands on the precipice of a significant paradigm shift following the release of the SINGLE-AF trial results. Unveiled during a high-profile Hot Line…